Navigation Links
MiMedx Announces Record Second Quarter Results
Date:7/31/2013

mniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® process, to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 160,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

Safe Harbor Statement
This press release includes statements that look forward in time or that express management's beliefs, expectations or hopes.  Such statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements include, but are not limited to, management's success in balancing EBITDA growth and investments in our sales organization to fuel revenue growth, the timing of publication of the results of clinical studies, the Company's revenue goals for the third quarter and full year 2013, the effect of reimbursement approval from MACs on the Company's revenue growth and the effectiveness of the Company's contingency plans in preventing any disruptions associated with moving the Company's processing and laboratory operations. These statements are based on current information and belief, and are not guarantees of future performance.  Among the risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements include, that management does not strike a successful balance between EBITDA growth and investments in sales, that incremental reimbursement approvals from MACs does not have the anticipated effect on revenue growth, that publications of clinical studies wil
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
2. MiMedx To Exceed High End Of Second Quarter Guidance
3. MiMedx to Ring NASDAQ Stock Market Opening Bell
4. MiMedx to Present at Jefferies 2013 Global Healthcare Conference
5. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
6. MiMedx Announces Record First Quarter 2013 Results
7. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
8. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
9. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
10. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
11. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... April 30, 2015 Oxford Finance LLC ("Oxford"), ... life sciences and healthcare services companies, today announced the ... agreement with Celula, Inc., a diagnostic testing company focused ... better patient care and improved outcomes.  Proceeds of the ... expand the commercialization of its products in the U.S. ...
(Date:4/30/2015)... , April 30, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that it ... Thursday, May 7, 2015 after the close of the ... call and webcast on Thursday, May 7, 2015 at ... the results and recent corporate developments. For ...
(Date:4/30/2015)... 2015 SureClinical, a leader in cloud-based ... has joined SureClinical’s executive team as Chief Financial Officer. ... technology executive with over 25 years in leadership roles ... , Ms. Morris joins SureClinical from Marrone Bio Innovations ... CFO of MBI from its founding in 2006 until ...
(Date:4/29/2015)... April 29, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... 31, 2014. Biorem,s complete fiscal 2014 year-end financial statements and MD&A have ... , 2013 , 2014 , 2013 ... 19,596 Gross profit 1,326 , 1,703 , ... 1,493 , 3,377 , 4,562 Ebitda* 92 ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Julie I. Morris Joins SureClinical as Chief Financial Officer 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4
... October 22, 2007 In a major feat of ... laser with a wide-range of potential applications in chemistry, ... nanoantenna, the device is capable of resolving the chemical ... cell, with unprecedented detail. , Spearheaded by graduate students ...
... Dr. Cindy Dennison Haines has,been named Managing ... for health and medical professionals. "We,re delighted ... managing,Physician,s Briefing,s editing and writing team," said Editor-in-Chief,Barry ... and,HealthDay, a leading daily health news service for ...
... Orchid Cellmark Inc.,(Nasdaq: ORCH ), a leading ... that it has signed a definitive purchase,agreement to ... a purchase price of $5.6 million in cash ... restricted common stock. The purchase price is,subject to ...
Cached Biology Technology:Harvard University engineers demonstrate quantum cascade laser nanoantenna 2Cynthia Haines, M.D., Named Managing Editor of Physician's Briefing News Wire 2Orchid Cellmark to Purchase ReliaGene Technologies, Inc. 2Orchid Cellmark to Purchase ReliaGene Technologies, Inc. 3
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, ... million users across iOS and Android ... begun integrating biofeedback into the platform to allow patients ... outcomes. For the first time, patients will be able ... a dose impacts important biometrics, such as glucose levels ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs , ... company, today announced that the Company will demonstrate multiple ... enterprise and consumers at Connect:ID on March 23 through ... HOYOS Labs will highlight the IEEE Biometric Open Protocol ... ; and enterprise access control system. BOPS was invented ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... to someone speak, we construct rich mental models that allow ... mental states and contexts. This ability to understand written or ... human mind and central to everyday social life. In a ... underlie discourse comprehension. The study appears in Brain ...
... Mo. Fish, unlike humans, can regenerate nerve connections and ... Now, University of Missouri researchers have discovered how the sea ... long nerve "highways" that link the brain to the spinal ... humans who have suffered spinal cord injuries. "There is ...
... have developed a bio-based solar cell. They embedded the ... are responsible of photosynthesis, into complex molecules developed in-house, ... Dr Wolfgang Schuhmann from the Department of Analytical Chemistry ... Matthias Rgner from the Department of Plant Biochemistry, the ...
Cached Biology News:Researchers map brain areas vital to understanding language 2MU research sheds light on nerve regeneration following spinal cord injury 2Bio-based solar cell 2